Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger
will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.

Carolinas HealthCare System

Research and Clinical Trials

Brief Description  
This study is looking at using Ceftolozane/tazobactam for the treatment of hospital acquired pneumonia. This medication has been approved for use in abdominal infections, however, its use for pneumonia is investigational. It will be compared to meropenem.
Who may be Eligible  
Eligible patients include: Patients are ventilated; proof of infiltrates on radiograph; meet clinical criteria as defined by the protocol; have normal maintenance labs as defined; not be treated with certain antibiotics prior to study; not be immunosuppressed; not have co-morbid conditions as defined by the protocol; contact the study team for details.
Start Date  
IRB Number  
Principal Investigator  
Polk, Christopher
Contact Name  

For More Information, Contact   Jessica  A.  Kearney-Bryan , BSN
Phone:  (704) 355-0244  Fax:  (l70) 446-7641 
Address:  1350 S. Kings Drive
Charlotte, NC 28207